Spravato

Spravato Treatment For Treatment-Resistant Depression

Understanding Spravato And How It Helps

Spravato (esketamine nasal spray) is an innovative treatment option designed for adults with treatment-resistant depression (TRD). For individuals who have had an inadequate response to traditional oral antidepressants, Spravato offers a faster, more targeted approach to help treat depression and improve overall well-being.

Spravato is FDA-approved and is primarily used to manage major depressive disorder (MDD), including cases with suicidal thoughts or acute suicidal ideation, providing relief for those who have not responded to standard treatments. Clinical studies show that Spravato can rapidly reduce depressive symptoms, giving patients a valuable opportunity to regain stability and re-engage in daily life (Daly et al., 2019)

You’re not alone: For many patients treated with traditional medications, untreated depression can feel overwhelming. Spravato offers hope through a carefully monitored, structured approach in certified healthcare settings.

How Spravato Nasal Spray Works

Spravato works differently than traditional antidepressants. Its primary target is NMDA (N-methyl-D-aspartate) receptors, which regulate glutamate, a key neurotransmitter involved in mood, motivation, and cognition. By modulating these receptors, Spravato strengthens neural connections that may be impaired in depression, helping to treat depressive symptoms more effectively (Zarate & Niciu, 2015)

Additional effects include influencing serotonin and dopamine levels, which are essential for emotional regulation. This combined impact helps patients achieve both rapid and sustained improvements in depression symptoms (Popova et al., 2019)

Key Mechanisms And Considerations

• Synaptic plasticity: Enhances neural connections disrupted by depression
• Rapid onset of action: Relief from depressive symptoms may be seen within hours to days
• Neurotransmitter regulation: Improves serotonin and dopamine function
• Close monitoring required: Due to potential respiratory depression, high blood pressure, and motor coordination issues

Because Spravato can have serious adverse outcomes, including sedation and the risk of drug abuse, each treatment session occurs under supervision by a healthcare professional in a restricted program called the Spravato REMS program. Patients remain in the office after administration until they are completely alert and safe to leave.

Who Can Benefit From Spravato

Spravato is specifically indicated for:

• Adults with treatment-resistant depression who have not responded to at least two oral antidepressants
• Individuals with major depressive disorder (MDD), particularly those experiencing suicidal thoughts
• Patients seeking a rapidly acting treatment when traditional antidepressants are ineffective

Clinical trials and real-world studies demonstrate that Spravato provides a meaningful reduction in depression symptoms, often when other treatments fail.

The Spravato Treatment Process

Spravato is administered as a nasal spray in healthcare settings certified to provide safe monitoring. The process includes:

1. Initial Assessment: Review of medical history, current medications, and potential risk factors such as aneurysmal vascular disease or high blood pressure.
2. First Dose Supervision: A healthcare provider monitors blood pressure, motor coordination, and breathing. Patients are observed for respiratory depression or other serious adverse outcomes.
3. Subsequent Treatment Sessions: Usually administered twice weekly initially, then tapered based on response and patient needs. Regular visits ensure safety and monitor depressive symptoms.
4. Combination With Oral Antidepressants: Spravato is always used in conjunction with an oral antidepressant to maximize efficacy.

Safety And Monitoring

• Blood pressure is checked before and after each session.
• Patients are monitored for respiratory depression, motor coordination issues, and sedation.
• Individuals are advised not to operate machinery for the rest of the day.
• Ongoing evaluation and mitigation strategies are applied to reduce the risks of drug abuse or respiratory arrest

Spravato’s REMS program ensures that only certified medical offices administer treatment, safeguarding patients throughout the process.

Potential Benefits Of Spravato

Spravato provides several advantages over conventional treatments:

• Rapid Relief: Many patients experience improvement in depressive symptoms within hours or days
• Effective For TRD: Work for those with inadequate response to multiple oral antidepressants
• Neuroplasticity Support: Helps restore abnormal connections impaired in depression.
• Improved daily functioning: Patients can engage more fully in work, relationships, and daily life

By enhancing serotonin, dopamine, and glutamate activity, Spravato offers both immediate and sustained improvements in major depressive disorder (MDD) symptoms.

Risks And Considerations

While Spravato is effective, it carries potential side effects:

• Transient blood pressure increases or high blood pressure.
• Sedation, dizziness, or motor coordination problems
• Nausea or headache, including a sudden, severe headache
• Risk of drug abuse if not administered in controlled healthcare settings
• Rare but serious risks like respiratory depression or respiratory arrest

Healthcare professionals will assess your medical history for conditions such as interstitial cystitis, ulcerative or interstitial cystitis, aneurysmal vascular disease, heart failure, or abdominal aorta issues before starting treatment.

Spravato And Suicidal Thoughts

Spravato can be life-saving for patients with suicidal ideation. By rapidly reducing depressive symptoms, Spravato helps stabilize mood and mitigate the risk of untreated depression leading to suicidal ideation.

Preventing suicide is a critical focus of the treatment-resistant depression TRD program, and Spravato’s fast-acting effects complement ongoing therapy and oral antidepressants.

Supporting Patients During Treatment

• Patients remain in the clinic for observation until fully alert.
• Healthcare providers educate on potential side effects and safe post-treatment activities.
• Encouraged to maintain regular visits and communicate changes in mood or depression symptoms
• Optional tracking with a depression symptom diary to assess improvements.

Begin Your Journey To Relief

Finding an effective solution for treatment-resistant depression can feel overwhelming, but you don’t have to face it alone. With Spravato treatment administered under the guidance of our experienced healthcare professionals, you have access to a carefully monitored, fast-acting option to help treat depressive symptoms and regain balance in daily life.

Schedule a consultation today at Mental Health And Wellness Of Southern Utah to discuss whether Spravato is the right option for you and take the first step toward renewed hope and improved well-being.